TVTX

NASDAQ · Biotechnology

Travere Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$26.84

-0.88 (-3.17%)

As of Mar 22, 10:00 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 86%

Hold 3 14%

Sell 0 0%

Price Target

Analyst Price Target +38.4% upside

Low Target $26.93

Average Target $37.15

High Target $48.45

Current Price $26.84

Current
$26.84

Target
$37.15

$26.93 $37.15 avg $48.45

Scenario Analysis

Bear Case

$26.93

0.3%

Low target

Base Case

$37.15

+38.4%

Avg target

Bull Case

$48.45

+80.5%

High target

Risk/Reward

240.1x

Highly favorable

Price in Context

52-Week High

$42.13

-36.3% from high

52-Week Low

$12.91

+107.9% from low

50-Day SMA

$32.84

-18.3% vs SMA

200-Day SMA

$24.79

+8.3% vs SMA

RSI (14)

40.3

Neutral

Target vs 52W High

$37.15

-11.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%